Navigation Links
Profectus Biosciences to Present at Key Investor Conference in January 2010
Date:1/8/2010

Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates to treat chronic viral infections, announced today that the company will present at the upcoming Biotech Showcase investor conference and will be attending the J.P. Morgan Healthcare Conference in San Francisco.

Baltimore, MD (Vocus) January 6, 2010 -- Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates to treat chronic viral infections, announced today that the company will present at the upcoming Biotech Showcase investor conference and will be attending the J.P. Morgan Healthcare Conference in San Francisco. These conferences will provide strategic investment and partnering opportunities for Profectus, whose novel ProfectusVAX™ prime/boost vaccines and NF-kB small molecule programs continue to progress on the cutting edge of research and development.

Dr. John Eldridge, Chief Scientific Officer of Profectus BioSciences, commented, “It is an exciting time for vaccine development. Recent clinical data have validated both prime/boost vaccination and the use of therapeutic vaccines to treat chronic viral infections. The Profectus vaccine program has made excellent progress over the past year and will be initiating three proof-of-concept clinical trials in collaboration with the National Institutes of Health (NIH) in 2010. In addition, we have generated very positive preclinical results in our NF-kB small molecule program. We look forward to sharing these successful corporate and R&D results at these conferences, and reaching our clinical milestones in 2010.”

2010 Biotech Showcase, January 12-13, 2010
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
2. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
3. Profectus BioSciences Inc. Names Shawn Patrick OBrien CEO
4. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
5. YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
6. Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone
7. Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure
8. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
9. YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT
10. YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
11. Cell Biosciences Acquires Protein Forest
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Profectus Biosciences to Present at Key Investor Conference in January 2010
(Date:7/10/2014)... help in the fight against terrorism with the creation ... explosives with the use of light and special glass ... Actuators B: Chemical , the researchers describe a novel ... as low as 6.3 ppm (parts per million). It ... , "Traditionally explosives detection has involved looking for metals ...
(Date:7/10/2014)... Hall effect in bilayer graphene and shown that this ... electric field. , The fractional quantum Hall effect, ... are exposed to large magnetic fields, is a striking ... behave as a single system. However, while the basic ... of this collective behavior remain not well understood, in ...
(Date:7/10/2014)... the University of Illinois at Urbana-Champaign provides new ... of spin and heat at the nanoscale, and ... for data storage and information processing. , ... momentum. In a typical charge current, electrons, spin-angular-momentum ... explained David Cahill, a professor of materials science ...
(Date:1/15/2014)... Automotive, a group of car dealerships headquartered in ... Center and offering free oil change coupons for participation in ... 18 at the Bill Jacobs Cadillac and Chevrolet location from ... )  The Bill Jacobs Auto annual blood ...
Breaking Biology Technology:Detecting trace amounts of explosives with light 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3University of Illinois study advances limits for ultrafast nano-devices 2Join the Bill Jacobs Auto blood drive and receive a free oil change 2
... , , ... board , Call by over 18% ... Significant funding shortfall identified in the Progen merger proposal , ... , Late last week Progen Pharmaceuticals Limited (ASX: PGL) responded to the ...
... Diffusion Pharmaceuticals LLC, a clinical-stage drug development company ... announced the completion of a $2.9 million private ... overall growth and clinical programs for its lead ... In addition, David G. Kalergis, Chief Executive Officer ...
... BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) ... year ended December 31, 2008. Fourth Quarter 2008 Financial ... 2008, the Company reported collaborative and other research and ... for the three months ended December 31, 2007. ...
Cached Biology Technology:Cytopia and Other Progen Shareholders Maintain Call for Meeting 2Cytopia and Other Progen Shareholders Maintain Call for Meeting 3Cytopia and Other Progen Shareholders Maintain Call for Meeting 4Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida 2Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida 3BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 2BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 3BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 4BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 5BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 6BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 7BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 8BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 9
(Date:7/10/2014)... 2014  Aware, Inc. (NASDAQ: AWRE ), ... announced on June 26, 2014 that its Board of ... per share, or approximately $40 million in total.  The ... and a payment date of July 24, 2014.  The ... set an ex-dividend date for this special cash dividend. ...
(Date:7/10/2014)... , July 2, 2014 It is ... to announce the appointment of the world-renowned Thoracic and ... of Directors. Dr. Ginsburg, with over 34 ... NY Presbyterian Hospital and Good Samaritan Regional Medical Center. ... since the late 1980,s and is considered an expert ...
(Date:7/10/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h7h8lq/gesture ... "Global Gesture Recognition & Touch-Less Sensing (2D, 3D, ... report to their offering ... & Touch-Less Sensing Market to Grow Exponentially. Touch-less ... but the companies were unable to leverage this ...
Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
... Barbara, Calif.) Coastal marine ecosystems are at risk worldwide ... UC Santa Barbara who have recently published a study in ... performed the first integrated analysis of all coastal areas of ... must address a litany of impacts from human activities, from ...
... publish The HUGO Journal in cooperation with the ... Genomic Medicine, The HUGO Journal has a new ... of HUGO will receive free access to the journal online ... The HUGO Journal will focus on discoveries ...
... PHILADELPHIAThe Academy of Natural Sciences announced today that its ... member of the prestigious Biodiversity Heritage Library. The BHL ... botanical libraries and research institutions worldwide dedicated to digitizing ... it and to make it more widely available. Scanning ...
Cached Biology News:New study ranks 'hotspots' of human impact on coastal areas 2Academy Library accepted to prestigious Biodiversity Heritage Library 2
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
...
Experion HighSens chips are the microfluidic chips used to perform high-sensitivity RNA analysis (picogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to ru...
Biology Products: